Biotech

All Articles

Galapagos stops briefly CAR-T cell treatment trial over Parkinsonism instance

.Galapagos has paused application in a test of a BCMA-directed CAR-T tissue treatment, pushing the b...

James Wilson leaving Penn to release two new biotechs

.After more than 30 years, genetics therapy innovator James Wilson M.D., Ph.D., is leaving the Educa...

3 biotechs try to defeat the summertime warmth by shedding personnel

.As biotechs seek to transform a fresh webpage in August, at least 3 firms have actually lost team i...

venBio elevates $528M for 5th life sciences VC fund

.Expert financial backing firm venBio has lifted another half a billion dollars to buy biotechs work...

Otsuka pays $800M for Jnana as well as its own clinical-stage PKU medication

.Otsuka Pharmaceutical has grabbed Boston-based Jnana Therapeutics for $800 thousand so the Eastern ...

FibroGen lays off 75% people staff as possession fails 2 additional tests

.FibroGen is actually drastically reorganizing its own service, giving up 75% of its own USA personn...

Tracon relax full weeks after injectable PD-L1 prevention stop working

.Tracon Pharmaceuticals has chosen to unwind functions full weeks after an injectable immune checkpo...

Ideaya bags possibility on Biocytogen bispecific ADC in $400M package

.Ideaya Biosciences is actually betting $400 million in biobucks that a bispecific antibody-drug con...

Takeda takes $140M reduction on fallen short epilepsy medication, promotes FDA run

.We already understand that Takeda is actually hoping to find a pathway to the FDA for epilepsy medi...

VBI Vaccinations apply for insolvency, finds asset purchase

.Immunology biotech VBI Vaccinations is actually veering dangerously close to the moment of truth, a...